CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)
Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants Who Plan to Receive a COVID-19 Vaccine Post-intervention |
19; 24; 19; 21; 24; 19 | — |
| SECONDARY Percentage of Participants Who Self-report COVID-19 Vaccine Uptake |
2; 1; 0; 0; 2; 1 | — |
Eligibility Criteria
Inclusion Criteria
- 18 years of age and older
- Must be eligible to receive a COVID-19 vaccine dose at the time of consent based on the following criteria:
a. Eligible for one bivalent mRNA vaccine i. No previous doses of any COVID-19 vaccine ii. At least 8 weeks since a previous vaccine dose of any manufacturer b. Eligible for second bivalent mRNA vaccine i. Adults 65 year of age and older can receive one additional bivalent mRNA vaccine at least 4 months after the first dose of a bivalent mRNA vaccine.
ii. Those who are immunocompromised can receive one additional bivalent mRNA vaccine at least 2 months after the first dose of a bivalent mRNA vaccine.
- Ability to read and speak English
Exclusion Criteria
- Those who have received all eligible doses of any approved COVID-19 vaccine.
- Those with active COVID-19 disease (either through self-reported positive test within the last 10 days or viral test at the event if available).
Data sourced from ClinicalTrials.gov (NCT05236270). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.